SynthesisFrontiers in endocrinology2024

Meta-analysis and systematic review: burosumab as a promising treatment for children with X-linked hypophosphatemia.

Kangning Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.